Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling

Autor: Maricela Castellon, Jiwang Chen, Marcelo G. Bonini, Suellen D. S. Oliveira, Xiaowu Gu, Roberto F. Machado, Richard D. Minshall, Michael H. Elliott
Rok vydání: 2017
Předmět:
Lipopolysaccharides
Male
0301 basic medicine
ARDS
Pathology
Time Factors
Physiology
Caveolin 1
030204 cardiovascular system & hematology
0302 clinical medicine
Transforming Growth Factor beta
Endothelial dysfunction
Lung
Respiratory Distress Syndrome
Middle Aged
Endothelial stem cell
Cytokines
Female
Inflammation Mediators
medicine.symptom
Bronchoalveolar Lavage Fluid
Research Article
Adult
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Nitric Oxide Synthase Type III
Acute Lung Injury
Inflammation
Acute respiratory distress
Pulmonary Artery
Vascular Remodeling
Lung injury
Biology
Bone Morphogenetic Protein Receptors
Type II

Models
Biological

03 medical and health sciences
Physiology (medical)
medicine
Animals
Humans
Cell Shape
Aged
Interleukin-6
Endothelial Cells
Cell Biology
medicine.disease
Actins
Mice
Inbred C57BL

030104 developmental biology
Proteolysis
Receptors
Transforming Growth Factor beta

Transforming growth factor
Zdroj: American Journal of Physiology-Lung Cellular and Molecular Physiology. 312:L760-L771
ISSN: 1522-1504
1040-0605
Popis: Endothelial cell (EC) activation and vascular injury are hallmark features of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Caveolin-1 (Cav-1) is highly expressed in pulmonary microvascular ECs and plays a key role in maintaining vascular homeostasis. The aim of this study was to determine if the lung inflammatory response to Escherichia coli lipopolysaccharide (LPS) promotes priming of ECs via Cav-1 depletion and if this contributes to the onset of pulmonary vascular remodeling. To test the hypothesis that depletion of Cav-1 primes ECs to respond to profibrotic signals, C57BL6 wild-type (WT) mice ( Tie2.Cre−;Cav1fl/fl) were exposed to nebulized LPS (10 mg; 1 h daily for 4 days) and compared with EC-specific Cav1−/−( Tie2.Cre+;Cav1fl/fl). After 96 h of LPS exposure, total lung Cav-1 and bone morphogenetic protein receptor type II (BMPRII) expression were reduced in WT mice. Moreover, plasma albumin leakage, infiltration of immune cells, and levels of IL-6/IL-6R and transforming growth factor-β (TGF-β) were elevated in both LPS-treated WT and EC-Cav1−/−mice. Finally, EC-Cav1−/−mice exhibited a modest increase in microvascular thickness basally and even more so on exposure to LPS (96 h). EC-Cav1−/−mice and LPS-treated WT mice exhibited reduced BMPRII expression and endothelial nitric oxide synthase uncoupling, which along with increased TGF-β promoted TGFβRI-dependent SMAD-2/3 phosphorylation. Finally, human lung sections from patients with ARDS displayed reduced EC Cav-1 expression, elevated TGF-β levels, and severe pulmonary vascular remodeling. Thus EC Cav-1 depletion, oxidative stress-mediated reduction in BMPRII expression, and enhanced TGF-β-driven SMAD-2/3 signaling promote pulmonary vascular remodeling in inflamed lungs.
Databáze: OpenAIRE